Yet another reason for improving approval and surveillance processes for health technologies

Spine J. 2011 Aug;11(8):800-1; author reply 801. doi: 10.1016/j.spinee.2011.06.019. Epub 2011 Jul 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Morphogenetic Protein 2 / adverse effects*
  • Humans
  • Male
  • Postoperative Complications / chemically induced*
  • Sexual Dysfunction, Physiological / chemically induced*
  • Spinal Fusion / adverse effects*
  • Spinal Fusion / methods*
  • Transforming Growth Factor beta / adverse effects*

Substances

  • Bone Morphogenetic Protein 2
  • Transforming Growth Factor beta